sa68535

The right name, the right stock code, the right OG x.com/i/status/20395…

@diabolicalcooks @elonmusk gg

@elonmusk 2c31roG4NE5xHnptgJtzjVDuChnq5hQWmy1cznwupump oldest

As sure as night follows day, the Golden State will eat its Golden Geese until there are no more left. gg

2c31roG4NE5xHnptgJtzjVDuChnq5hQWmy1cznwupump

OG $GG 2c31roG4NE5xHnptgJtzjVDuChnq5hQWmy1cznwupump

@VVmmao 骗局啊被盗了

FFB9u2SvohpewHRRedoQPLfYu3TbxwkGybXxoFGUpump 创始人已经回复了 手续费全部是他 希望能够固定ca可能是个大市值

@tige_sol @john_zippay Bundled with 40% off??????????

@john_zippay we made a coin!! all fees have been sent to the wallet JCs6x7Pp6wuRJJaYZFhQM74wcGc86dxwi2ZyopjDX9fH 9USxheBsxJZK6XEtQ1nkmqXAUcd6WUKGnLT595fSpump

@sandyXBT Put it in your left pocket and take it out of your right pocket

Does this coin look like it has a $1M daily buyback ?

@yimo2024 啥情况

卧槽 黑客盗了他妈超多SOL 放屁币也盗了超多

@Bl0ckZer0 Why do we need control

6VDkXHp2JRDRepwezr5894ebamApVnE2QRZC3k2jpump $Freenoc is still free money 5k mc

@0xWeiGe123 那你给他试试

克劳德说我用10u能用一个策略就赚到8320倍，也就是83200u

@Pipstune @narracanz ca

Same deployer with $Alon coin Ath hit 260M mcap @narracanz

@yimo2024 还是得有人带头建设群

这个代币的诞生环境还是建立在这条爆火的2M的推文上面的。这种标我炒币这么久也就遇到这一次。

FX9rJbMpJi9yHERwZ14Qqbr7VSrrieDNGA4Nm5DzTRND 这个日本男优是日本最出名的 他的粉丝很多日本有钱人 他以调侃的口吻发推文跟这枚代币互动说明并不是很抵触加密货币 如果他领取手续费的话很大概率可能是下一个索拉拉 加上最近SOLANA跟马斯克都在推动日本元素 自己做研究吧 人生有得几回搏

@yimo2024 @yooo_pumpfun @feibo03 @mablejiang @yuuki_yuduru @gmgnai 我买了，别盖

@yooo_pumpfun @feibo03 @mablejiang @yuuki_yuduru @gmgnai 实话说，这男的粉丝很多日本有钱人，如果爆发几M都有可能

【速報】『また中国人にネットのおもちゃにされてる…トークン』爆誕 誰や勝手に作ったやつ！！

Cr7TMJRcaLMPcac6nnm4LabCffqDqZyXzUKk5wuLTRiX官方自己的

@momo_mattomo @JohnSchloendorn ca

This is a fascinating (and slightly dystopian) glimpse into the future of biotech. Bay Area startup R3 Bio, co-founded by @JohnSchloendorn and Alice Gilman, is engineering "bodyoids", genetically modified, brainless organ systems grown from stem cells (starting with monkey cells, with eyes on human versions). These nonsentient "organ sacks" aim to provide far more accurate, human-relevant platforms for drug toxicity testing and disease modeling than traditional animal experiments. The timing is no coincidence: the Trump administration has aggressively pushed to phase out federal reliance on animal testing. In 2025, the FDA announced plans to reduce or replace animal requirements (especially for monoclonal antibodies and other drugs), followed by 2026 draft guidance on validating New Approach Methodologies (NAMs) like organoids and integrated tissue systems. R3 Bio stands out as a bold, billionaire-backed player (with support from Tim Draper, Immortal Dragons, and LongGame Ventures) in this shift which highlights how private innovation like Schloendorn's vision could accelerate the move away from animal models toward ethical, scalable biotech solutions. Long-term ambitions even include using these bodyoids as sources for transplant organs, though that's still speculative and raises deep ethical questions. Exciting progress in reducing animal suffering, but it demands careful oversight as the science races ahead.

@finnbags Don't let this chance to make bags popular again slip away

@cobie @john_zippay Wow there's a coin on @BagsApp trying to save J.O C1yvhZkdrkx8Nx6AgJyTb6LLEVxhEy8dA8xao7bCBAGS

Bro this is alpha When he claims this goes millions C1yvhZkdrkx8Nx6AgJyTb6LLEVxhEy8dA8xao7bCBAGS @finnbags we need your Finn moments!!!